Inspire Medical Systems, Inc. to Report First Quarter 2025 Financial Results on May 5, 2025

Rhea-AI Summary

Inspire Medical Systems (NYSE: INSP) has scheduled its first quarter 2025 financial results release for Monday, May 5, 2025, after market close. The company will host a conference call at 5:00 p.m. Eastern Time to discuss the quarterly results and recent business developments.

The earnings call will be accessible through two options: a webcast via the company's Investor Relations page for listeners, and a separate registration link for participants planning to ask questions. Participants are advised to register at least 10 minutes before the call. A replay will be available on the Investor Relations website approximately two hours after the event and will be archived for two weeks.

MINNEAPOLIS, April 01, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the first quarter 2025 after the close of trading on Monday, May 5. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.

A webcast of the call will be accessible via the Investor Relations page of the Inspire website or through this link: Inspire's Q1 2025 earnings call webcast. For those not planning to ask a question of management, the Company recommends listening via the webcast.

If you plan to ask a question, please use the following link: Inspire's Q1 2025 earnings call. After registering, an email will be sent, including dial-in details and a unique conference call access code required to join the live call. To ensure you are connected prior to the beginning of the call, the Company suggests registering a minimum of 10 minutes before the start of the call. 

Following the call, a replay will be available on the Company's Investor Relations website approximately two hours after the event and archived on the site for two weeks.

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443

FAQ

When will Inspire Medical Systems (INSP) release Q1 2025 earnings?

Inspire Medical Systems will release Q1 2025 earnings after market close on Monday, May 5, 2025.

What time is Inspire Medical Systems (INSP) Q1 2025 earnings call?

The earnings call is scheduled for 5:00 p.m. Eastern Time on May 5, 2025.

How can investors access INSP's Q1 2025 earnings call?

Investors can access the call via webcast on Inspire's Investor Relations page or register separately to ask questions during the call.

How long will INSP's Q1 2025 earnings call replay be available?

The earnings call replay will be available on the Investor Relations website for two weeks after the event.